Viracta Therapeutics, Inc.

VIRX · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Assets
Cash & Equivalents$13,127$13,981$12,062$12,317
Short-Term Investments$8,005$16,024$27,504$41,374
Receivables$0$0$0$281
Inventory$0$0$0$0
Other Curr. Assets$671$1,067$1,386$992
Total Curr. Assets$21,803$31,072$40,952$54,964
Property Plant & Equip (Net)$111$206$338$464
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$44$44$44$1,264
Total NC Assets$155$250$382$1,728
Other Assets$0$0$0$0
Total Assets$21,958$31,322$41,334$56,692
Liabilities
Payables$1,817$1,286$2,412$2,441
Short-Term Debt$16,911$18,819$18,857$25,556
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$9,847$8,546$8,985$10,376
Total Curr. Liab.$28,575$28,651$30,254$38,373
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$73$179$282
Total Liabilities$28,575$28,651$30,254$38,373
Equity
Pref Stock$0$5,452$5,452$5,452
Common Stock$4$4$4$4
Retained Earnings-$295,456-$284,903-$275,073-$265,932
AOCI$9-$5-$6$9
Other Equity$288,826$282,123$280,703$278,786
Total Equity-$6,617$2,671$11,080$18,319
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$21,958$31,322$41,334$56,692
Net Debt$3,784$4,838$6,795$13,239